{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:13:44Z","timestamp":1778782424618,"version":"3.51.4"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010669","name":"Department of Health of Shandong Province","doi-asserted-by":"publisher","award":["202404051149"],"award-info":[{"award-number":["202404051149"]}],"id":[{"id":"10.13039\/501100010669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clear cell renal cell carcinoma (ccRCC) is highly heterogeneous, and robust biomarkers for risk stratification and therapeutic guidance remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated single-cell RNA sequencing (scRNA-seq) of tumor and adjacent tissues with multi-cohort transcriptomic validation. High-dimensional weighted gene co-expression network analysis (hdWGCNA) was applied to identify pathogenic immune subsets and candidate genes. Prognostic modeling was performed using CoxBoost, and UBE2S function was validated by in vitro knockdown assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>scRNA-seq revealed extensive remodeling of the tumor microenvironment, highlighting NK cell subpopulations with strong intercellular signaling. hdWGCNA identified 12 core genes enriched in protein processing and MAPK pathways, with UBE2S emerging as the top driver. A CoxBoost-based 12-gene signature demonstrated robust predictive accuracy across independent datasets. Functionally, UBE2S knockdown suppressed ccRCC cell proliferation and migration, while immune correlation analyses linked UBE2S to altered tumor immunogenicity and genomic stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study identifies NK cell subsets and UBE2S as key contributors to ccRCC progression and establishes a clinically relevant 12-gene prognostic model, offering potential targets for precision therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0344925","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:37:31Z","timestamp":1778780251000},"page":"e0344925","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["UBE2S emerges as a key driver in an NK cell\u2013based prognostic model for clear cell renal cell carcinoma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4754-2531","authenticated-orcid":true,"given":"Kang","family":"Leng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"21","key":"pone.0344925.ref001","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.12998\/wjcc.v7.i21.3474","article-title":"Characteristics of clear cell renal cell carcinoma metastases to the thyroid gland: A systematic review","volume":"7","author":"K Khaddour","year":"2019","journal-title":"World J Clin Cases"},{"issue":"4","key":"pone.0344925.ref002","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4291\/wjgp.v7.i4.314","article-title":"Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis","volume":"7","author":"K Wijarnpreecha","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"1","key":"pone.0344925.ref003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11934-025-01276-2","article-title":"Multiomics in renal cell carcinoma: Current landscape and future directions for precision medicine","volume":"26","author":"F Gavi","year":"2025","journal-title":"Curr Urol Rep"},{"issue":"2","key":"pone.0344925.ref004","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13277-013-1160-x","article-title":"The association between HIF-1\u03b1 polymorphism and cancer risk: A systematic review and meta-analysis","volume":"35","author":"X Hu","year":"2014","journal-title":"Tumour Biol"},{"key":"pone.0344925.ref005","doi-asserted-by":"crossref","first-page":"130366","DOI":"10.1016\/j.bmcl.2025.130366","article-title":"Structure-activity relationship study of HIF-2\u03b1 inhibitors with tricyclic scaffold","volume":"129","author":"Z Wu","year":"2025","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"pone.0344925.ref006","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"S Bahadoram","year":"2022","journal-title":"G Ital Nefrol"},{"issue":"2","key":"pone.0344925.ref007","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/JS9.0000000000000935","article-title":"Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: A prospective population-based study with multicenter validation","volume":"110","author":"Y Wang","year":"2024","journal-title":"Int J Surg"},{"issue":"5","key":"pone.0344925.ref008","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.eururo.2022.01.040","article-title":"Novel imaging methods for renal mass characterization: A collaborative review","volume":"81","author":"E Roussel","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"pone.0344925.ref009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-023-01911-x","article-title":"Evolution of cell therapy for renal cell carcinoma","volume":"23","author":"Y Wang","year":"2024","journal-title":"Mol Cancer"},{"issue":"4","key":"pone.0344925.ref010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3325\/cmj.2025.66.299","article-title":"Multimodal treatment approach with sunitinib, pembrolizumab, bevacizumab, sirolimus, and zoledronic acid for locally advanced clear cell renal cell carcinoma: A case report","volume":"66","author":"M Mehrabi","year":"2025","journal-title":"Croat Med J"},{"issue":"9","key":"pone.0344925.ref011","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1158\/2767-9764.CRC-25-0337","article-title":"Prognostic impact of immune-related adverse events on combination immune checkpoint\/tyrosine kinase inhibition for metastatic renal cancer","volume":"5","author":"B Isoda","year":"2025","journal-title":"Cancer Res Commun"},{"issue":"36","key":"pone.0344925.ref012","article-title":"Lipid-based nanoparticles in cancer therapy: advances in targeted drug delivery and therapeutic potential for renal cell carcinoma","volume":"12","author":"W Yao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"pone.0344925.ref013","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/cells13010034","article-title":"Emerging immunotherapy approaches for advanced clear cell renal cell carcinoma","volume":"13","author":"L Meng","year":"2023","journal-title":"Cells"},{"key":"pone.0344925.ref014","doi-asserted-by":"crossref","first-page":"217984","DOI":"10.1016\/j.canlet.2025.217984","article-title":"Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress","volume":"633","author":"A Sabarwal","year":"2025","journal-title":"Cancer Lett"},{"issue":"1","key":"pone.0344925.ref015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1186\/s12967-025-06882-9","article-title":"GPD1L as a potential biomarker associated with Treg cell infiltration and lipid metabolism in clear cell renal cell carcinoma","volume":"23","author":"M Yang","year":"2025","journal-title":"J Transl Med"},{"key":"pone.0344925.ref016","doi-asserted-by":"crossref","first-page":"1602898","DOI":"10.3389\/fimmu.2025.1602898","article-title":"Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model","volume":"16","author":"Z Xie","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0344925.ref017","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.70026","article-title":"Natural Products and lncRNAs in Renal Cell Carcinoma: Emerging therapeutic approaches","volume":"27","author":"AS Doghish","year":"2025","journal-title":"J Gene Med"},{"issue":"9","key":"pone.0344925.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae512","article-title":"Identifying cancer cells from calling single-nucleotide variants in scRNA-seq data","volume":"40","author":"V Marot-Lassauzaie","year":"2024","journal-title":"Bioinformatics"},{"issue":"8","key":"pone.0344925.ref019","first-page":"1015","article-title":"Novel Insights into T-Cell Exhaustion and Cancer Biomarkers in PDAC Using ScRNA-Seq","volume":"14","author":"MU Saleem","year":"2025","journal-title":"Biology (Basel)"},{"issue":"1","key":"pone.0344925.ref020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12885-025-13534-0","article-title":"Identification and validation of prognostic biomarkers in ccRCC: Immune-stromal score and survival prediction","volume":"25","author":"F Lyu","year":"2025","journal-title":"BMC Cancer"},{"key":"pone.0344925.ref021","doi-asserted-by":"crossref","first-page":"178120","DOI":"10.1016\/j.ejphar.2025.178120","article-title":"KPNA2 expression as a biomarker for immunosuppressive microenvironment predicting response to TKI and immunotherapy in metastatic renal cell carcinoma","volume":"1006","author":"X Xu","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"pone.0344925.ref022","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.3390\/ijms26125577","article-title":"Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC)","volume":"26","author":"J Rysz","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0344925.ref023","doi-asserted-by":"crossref","first-page":"20533","DOI":"10.1038\/s41598-025-06051-4","article-title":"Regulatory T cells and matrix-producing cancer-associated fibroblasts in immune resistance and prognosis-related tumor subtypes in ccRCC","volume":"15","author":"C Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"pone.0344925.ref024","article-title":"Regulatory role and mechanism of TGFBI on Tregs in clear cell renal cell carcinoma immune microenvironment","author":"X Hao","year":"2025","journal-title":"Int J Surg"},{"issue":"11","key":"pone.0344925.ref025","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.7150\/thno.109097","article-title":"Spatially segregated APOE+ macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma","volume":"15","author":"Q Ge","year":"2025","journal-title":"Theranostics"},{"key":"pone.0344925.ref026","doi-asserted-by":"crossref","first-page":"1630250","DOI":"10.3389\/fmolb.2025.1630250","article-title":"Identification of kidney renal clear cell carcinoma prognosis based on gene expression and clinical information","volume":"12","author":"X Zou","year":"2025","journal-title":"Front Mol Biosci"},{"issue":"13","key":"pone.0344925.ref027","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Y Hao","year":"2021","journal-title":"Cell"},{"issue":"5","key":"pone.0344925.ref028","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"G Yu","year":"2012","journal-title":"OMICS"},{"issue":"6","key":"pone.0344925.ref029","doi-asserted-by":"crossref","first-page":"100498","DOI":"10.1016\/j.crmeth.2023.100498","article-title":"hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data","volume":"3","author":"S Morabito","year":"2023","journal-title":"Cell Rep Methods"},{"issue":"1","key":"pone.0344925.ref030","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"S Jin","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0344925.ref031","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"T Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"pone.0344925.ref032","doi-asserted-by":"crossref","first-page":"1494106","DOI":"10.3389\/fimmu.2024.1494106","article-title":"Single-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia","volume":"15","author":"G He","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"pone.0344925.ref033","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3892\/ol.2025.15245","article-title":"Quantitative analysis of lymphocyte exhaustion markers in patients with localized clear cell renal cell carcinoma","volume":"30","author":"R Gonz\u00e1lez-Garza","year":"2025","journal-title":"Oncol Lett"},{"issue":"4","key":"pone.0344925.ref034","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"E Jonasch","year":"2021","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"pone.0344925.ref035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24465","article-title":"Diverse roles of UBE2S in cancer and therapy resistance","volume":"10","author":"M Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"pone.0344925.ref036","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ol.2024.14743","article-title":"Roles of deubiquitinases in urologic cancers (Review)","volume":"28","author":"L Wu","year":"2024","journal-title":"Oncol Lett"},{"issue":"11","key":"pone.0344925.ref037","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.21037\/tcr-2025-620","article-title":"Ubiquitin-conjugating enzyme E2S serves as a prognostic marker for skin cutaneous melanoma","volume":"14","author":"G Du","year":"2025","journal-title":"Transl Cancer Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:37:38Z","timestamp":1778780258000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344925"}},"subtitle":[],"editor":[{"given":"Sercan","family":"Erg\u00fcn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344925","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}